top of page

Learn More About Semaglutide, Tirzepatide, and Retatrutide

Semaglutide

(Single Stage Hormone)

 

​​​Semaglutide only activates the GLP-1 receptors for moderate weight loss with minor symptoms, though sometimes the nausea can assist with avoiding certain foods long term.

​

​(15-20% weight loss)

Tirzepatide

(Double Stage Hormone)

​

Tirzepatide is designed to activate the GLP-1, GIP, and Glucagon receptors simultaneously, which can lead to greater reductions in blood sugar levels compared to hormones that only target one of these receptors. In addition, Tirzepatide has been shown to promote weight loss and improve/help cardiovascular risk factors such as blood pressure and cholesterol levels.

​

(20-25% weight loss)

Retatrutide

(Triple Stage Hormone)

​

Designed to activate the GLP-1, GIP, and Glucagon receptors simultaneously, This triple function helps regulate appetite and promotes a feeling of fullness. Enhances insulin secretion and supports metabolic function.  Boosts energy expenditure and fat breakdown while not causing much muscle wasting as you see in both Semaglutide and Tirzepatide.

 

(25-30% weight loss)

GLP-1 (Glucagon-Like Peptide-1): Helps regulate appetite and promotes a feeling of fullness.

​

GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances insulin secretion and supports metabolic function.

​

Glucagon Receptor: Boosts energy expenditure and fat breakdown without much muscle loss.

logomark-color-white_edited.png

About Us

At Guardian Global Health, we’re here to support you and your family on the journey to optimal health through personalized life management and hormone opportunities. We create a warm and welcoming environment where every member can feel empowered to make lasting changes together. With compassionate guidance and individualized care, we are dedicated to helping you and your loved ones achieve and maintain a healthier future together."

 

© 2025 by Guardian Global Health Powered and secured by Wix

bottom of page